Provided by Tiger Trade Technology Pte. Ltd.

Werewolf Therapeutics, Inc.

0.8269
+0.00340.41%
Volume:32.23K
Turnover:26.81K
Market Cap:40.14M
PE:-0.51
High:0.8590
Open:0.8590
Low:0.7903
Close:0.8235
52wk High:2.38
52wk Low:0.5301
Shares:48.54M
Float Shares:35.00M
Volume Ratio:0.82
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6177
EPS(LYR):-1.6273
ROE:-122.43%
ROA:-40.75%
PB:1.36
PE(LYR):-0.51

Loading ...

Wedbush Downgrades Werewolf Therapeutics to Neutral From Outperform Due to 'Forward Challenging' Path, Cuts Price Target to $1 From $3

MT Newswires Live
·
Dec 19, 2025

Werewolf Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 19, 2025

BRIEF-Werewolf Therapeutics Inc - Plans For Two Inds By Mid-2027

Reuters
·
Dec 18, 2025

Werewolf Therapeutics Inc - Plans for Two Inds by Mid-2027

THOMSON REUTERS
·
Dec 18, 2025

Werewolf Therapeutics Reports Promising Phase 1 Data for WTX-124 and WTX-330 in Advanced Cancer Trials

Reuters
·
Dec 18, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 18, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 13, 2025

Director Luke Evnin Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 10, 2025

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 05, 2025

Former 10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 05, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02, 2025

MPM BioVentures 2014 L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02, 2025

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 26, 2025

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 26, 2025

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Common Shares

Reuters
·
Nov 26, 2025

Werewolf Therapeutics Is Maintained at Buy by B of A Securities

Dow Jones
·
Nov 19, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 18, 2025

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 18, 2025

10% Owner Ansbert Gadicke Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 18, 2025